[Federal Register Volume 67, Number 99 (Wednesday, May 22, 2002)]
[Notices]
[Page 36013]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-12764]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel; Stantin 
Clinical Trial.
    Date: May 24, 2002.
    Time: 8:30 AM to 1:00 PM.
    Agenda: To review and evaluate grant applications.
    Place: Double Tree Hotel, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Tommy L. Broadwater, PHD, Chief, Review Branch, 
National Institute of Arthritis and Musculoskeletal and Skin 
Diseases, Natcher Building/MSC 6500, 45 Center Drive, Room 5AS-25U, 
Bethesda, MD 20892, 301-594-4952.

    This notice is being published less than 15 days prior to the 
meetings due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS)

    Dated: May 14, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-12764 Filed 5-21-02; 8:45 am]
BILLING CODE 4140-01-M